1921
Volume 83, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Standardized antimycobacterial therapy is considered the treatment of choice for Buruli ulcer disease. To assess the prevalence of drug resistance among clinical isolates in Ghana, we conducted a sequence-based approach to detect mutations associated with drug resistance. We subjected clinical samples to direct DNA sequencing of and genes and compared culture and whole-genome extracts regarding the efficiency of sequence analysis; 99.1% () and 100% () of the patients harbored wild type. In one isolate (0.9%), a point mutation of the gene at codon Ser522 leading to an amino acid change was detected. Culture extracts yielded a significantly higher sequencing efficiency than whole-genome extracts. Our data suggest a low level of drug resistance in Ghana. However, mutations associated with drug resistance do occur and require monitoring. Improved techniques are necessary to enhance the efficiency of sequence analysis of whole-genome extracts.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.10-0263
2010-11-05
2017-11-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/83/5/1059.html?itemId=/content/journals/10.4269/ajtmh.2010.10-0263&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2008. Buruli ulcer: progress report, 2004–2008. Wkly Epidemiol Rec 17: 145154.
  2. World Health Organization, 2004. Provisional Guidance on the Role of Specific Antibiotics in the Management of Mycobacterium ulcerans Disease (Buruli Ulcer). Geneva, Switzerland: World Health Organization.
  3. Siegmund V, Adjei O, Nitschke J, Thompson W, Klutse E, Herbinger KH, Thompson R, van Vloten F, Racz P, Fleischer B, Loescher T, Bretzel G, , 2007. Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease. Clin Infect Dis 45: 6875.[Crossref]
  4. Schunk M, Thompson W, Klutse E, Nitschke J, Opare-Asamoah K, Thompson R, Fleischmann E, Siegmund V, Herbinger KH, Adjei O, Fleischer B, Loscher T, Bretzel G, , 2009. Outcome of patients with Buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana. Am J Trop Med Hyg 81: 7581.
  5. Herbinger KH, Adjei O, Awua-Boateng NY, Nienhuis WA, Kunaa L, Siegmund V, Nitschke J, Thompson W, Klutse E, Agbenorku P, Schipf A, Reu S, Racz P, Fleischer B, Beissner M, Fleischmann E, Helfrich K, van der Werf TS, Loscher T, Bretzel G, , 2009. Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 48: 10551064.[Crossref]
  6. World Health Organization, 2008. Anti-Tuberculosis Drug Resistance in the World. Report No. 4 . Geneva, Switzerland: World Health Organization.
  7. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, Simpson J, Gie RP, Enarson DA, Beyers N, van Helden PD, Victor TC, , 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39: 636641.[Crossref]
  8. Telenti A, Honore N, Bernasconi C, March J, Ortega A, Heym B, Takiff HE, Cole ST, , 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35: 719723.
  9. World Health Organization, 2007. Rifampicin Resistance in Leprosy. Report of an Informal Consultation. Geneva, Switzerland: World Health Organization.
  10. Matsuoka M, Budiawan T, Aye KS, Kyaw K, Tan EV, Cruz ED, Gelber R, Saunderson P, Balagon V, Pannikar V, , 2007. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr Rev 78: 343352.
  11. World Health Organization, 2009. Guidelines for Global Surveillance of Drug Resistance in Leprosy. Geneva, Switzerland: World Health Organization.
  12. Morlock GP, Plikaytis BB, Crawford JT, , 2000. Characterization of spontaneous in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother 44: 32983301.[Crossref]
  13. Sapkota BR, Ranjit C, Neupane KD, Macdonald M, , 2008. Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae . J Med Microbiol 57: 179184.[Crossref]
  14. Das R, Gupta P, Singh P, Chauhan DS, Katoch K, Katoch VM, , 2009. Association of mutations in rpsL gene with high degree of streptomycin resistance in clinical isolates of Mycobacterium tuberculosis in India. Indian J Med Res 129: 108110.
  15. Mieskes KT, Rusch-Gerdes S, Truffot-Pernot C, Feldmann K, Tortoli E, Casal M, Loscher T, Rinder H, , 2000. Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis . Am J Trop Med Hyg 63: 5660.
  16. Marsollier L, Honore N, Legras P, Manceau AL, Kouakou H, Carbonnelle B, Cole ST, , 2003. Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. Antimicrob Agents Chemother 47: 12281232.[Crossref]
  17. Nienhuis WA, Stienstra Y, Thompson WA, Awuah PC, Abass KM, Tuah W, Awua-Boateng NY, Ampadu EO, Siegmund V, Schouten JP, Adjei O, Bretzel G, van der Werf TS, , 2010. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomized controlled trial. Lancet 375: 664672.[Crossref]
  18. Stinear T, Ross BC, Davies JK, Marino L, Robins-Browne RM, Oppedisano F, Sievers A, Johnson PD, , 1999. Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol 37: 10181023.
  19. Siegmund V, Adjei O, Racz P, Berberich C, Klutse E, van Vloten F, Kruppa T, Fleischer B, Bretzel G, , 2005. Dry reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic. J Clin Microbiol 43: 271276.[Crossref]
  20. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson R, Fleischmann E, Fleischer B, Adjei O, , 2006. External quality assurance for the laboratory diagnosis of Buruli ulcer disease in Ghana. Trop Med Int Health 11: 16881693.[Crossref]
  21. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, Klutse E, Crofts K, Massavon W, Etuaful S, Thompson R, Asamoah-Opare K, Racz P, Vloten F, van Berberich C, Kruppa T, Ampadu E, Fleischer B, Adjei O, , 2007. A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health 12: 8996.
  22. Kim BJ, Lee SH, Lyu MA, Kim SJ, Bai GH, Chae GT, Kim EC, Cha CY, Kook YH, , 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 37: 17141720.
  23. Talaat AM, Reimschuessel R, Trucksis M, , 1997. Identification of mycobacteria infecting fish to the species level using polymerase chain reaction and restriction enzyme analysis. Vet Microbiol 58: 229237.[Crossref]
  24. Turenne CY, Tschetter L, Wolfe J, Kabani A, , 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 39: 36373648.[Crossref]
  25. Kim H, Kim SH, Shim TS, Kim MN, Bai GH, Park YG, Lee SH, Cha CY, Kook YH, Kim BJ, , 2005. PCR restriction fragment length polymorphism analysis (PRA)-algorithm targeting 644 bp Heat Shock Protein 65 (hsp65) gene for differentiation of Mycobacterium spp. J Microbiol Methods 62: 199209.[Crossref]
  26. Roth A, Reischl U, Streubel A, Naumann L, Kroppenstedt RM, Habicht M, Fischer M, Mauch H, , 2000. Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. J Clin Microbiol 38: 10941104.
  27. World Health Organization, 2007. Summary Report of the WHO Annual Meeting on Buruli Ulcer. Geneva, Switzerland: World Health Organization.
  28. Eddyani M, Ofori-Adjei D, Teugels G, De Weirdt D, Boakye D, Meyers WM, Portaels F, , 2004. Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol 70: 56795681.[Crossref]
  29. Johnson PD, Azuolas J, Lavender CJ, Wishart E, Stinear TP, Hayman JA, Brown L, Jenkin GA, Fyfe JA, , 2007. Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis 13: 16531660.[Crossref]
  30. van der Werf TS, Stienstra Y, Johnson RC, Phillips R, Adjei O, Fleischer B, Wansbrough-Jones MH, Johnson PD, Portaels F, van der Graaf WT, Asiedu K, , 2005. Mycobacterium ulcerans disease. Bull World Health Organ 83: 785791.
  31. Debacker M, Zinsou C, Aguiar J, Meyers WM, Portaels F, , 2003. First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite. Clin Infect Dis 36: e67e68.[Crossref]
  32. Maranes Antonanzas I, Lopez Gallardo Y, Garcia Pardo A, Abella Vazquez ML, , 2006. Transmission of Buruli ulcer from person to person. Rev Clin Esp 206: 256257.[Crossref]
  33. Asiedu K, Wansbrough-Jones M, , 2007. Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies. Med J Aust 186: 5556.
  34. Eddyani M, Debacker M, Martin A, Aguiar J, Johnson CR, Uwizeye C, Fissette K, Portaels F, , 2008. Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol 46: 6972.[Crossref]
  35. Pierre-Audigier C, , 1994. Recent biological techniques for the diagnosis of mycobacterial infections. Presse Med 23: 665670.
  36. Hosek J, Svastova P, Moravkova M, Pavlik I, Bartos M, , 2006. Methods of mycobacterial DNA isolation from different biological material: a review. Vet Med (Praha) 51: 180192.
  37. Marsollier L, Robert R, Aubry J, Saint Andre JP, Kouakou H, Legras P, Manceau AL, Mahaza C, Carbonnelle B, , 2002. Aquatic insects as a vector for Mycobacterium ulcerans . Appl Environ Microbiol 68: 46234628.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.10-0263
Loading
/content/journals/10.4269/ajtmh.2010.10-0263
Loading

Data & Media loading...

  • Received : 09 May 2010
  • Accepted : 30 Jul 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error